An epigenetic lesion could result in T-cell acute lymphoblastic leukemia
Researchers at the Bellvitge Biomedical Research Institute (Barcelona, Spain) have identified that an epigenetic lesion can to T-cell leukemia, which could be treated by epigenetic drugs.
Please sign in or register for FREE to view this content
Sign in to EpigenomicsNet
Register to EpigenomicsNet – the epigenetics and epigenomics network
EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.